{"organizations": [], "uuid": "0b6eeca086e3ee3d0f209ea6a9398fee3f8879e1", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.cnbc.com", "main_image": "https://fm.cnbc.com/applications/cnbc.com/resources/img/editorial/2018/01/08/104934402-2ED1-REQ-BiomarinTirrell-010818.600x400.jpg", "site_section": "http://www.cnbc.com/id/19746125/device/rss/rss.xml", "section_title": "Top News and Analysis (pro)", "url": "https://www.cnbc.com/video/2018/01/08/biomarin-ceo-on-hemophilia-treatment-success.html", "country": "US", "domain_rank": 767, "title": "BioMarin CEO on hemophilia treatment success", "performance_score": 0, "site": "cnbc.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-01-08T21:00:00.000+02:00", "replies_count": 0, "uuid": "0b6eeca086e3ee3d0f209ea6a9398fee3f8879e1"}, "author": "", "url": "https://www.cnbc.com/video/2018/01/08/biomarin-ceo-on-hemophilia-treatment-success.html", "ord_in_thread": 0, "title": "BioMarin CEO on hemophilia treatment success", "locations": [], "entities": {"persons": [{"name": "jean-jacques bienaime discusse", "sentiment": "negative"}], "locations": [{"name": "san francisco", "sentiment": "none"}], "organizations": [{"name": "biomarin", "sentiment": "negative"}, {"name": "j.p. morgan health", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "BioMarin CEO on hemophilia treatment success 2 Hours Ago BioMarin CEO Jean-Jacques Bienaime discusses the company's hemophilia A treatment at J.P. Morgan Health in San Francisco.", "external_links": [], "published": "2018-01-08T21:00:00.000+02:00", "crawled": "2018-01-08T23:39:00.013+02:00", "highlightTitle": ""}